2.60
price up icon1.56%   0.04
 
loading
Cronos Group Inc stock is traded at $2.60, with a volume of 2.79M. It is up +1.56% in the last 24 hours and up +21.50% over the past month. Cronos Group Inc headquartered in Toronto, Canada, cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis primarily to Israel. In the U.S., the company has an option to acquire 5.9% of U.S. multistate operator PharmaCann on a fully diluted basis upon easing of federal prohibition.
See More
Previous Close:
$2.56
Open:
$2.55
24h Volume:
2.79M
Relative Volume:
1.45
Market Cap:
$995.90M
Revenue:
$87.89M
Net Income/Loss:
$-73.96M
P/E Ratio:
-14.11
EPS:
-0.1843
Net Cash Flow:
$-46.26M
1W Performance:
+9.70%
1M Performance:
+21.50%
6M Performance:
+31.98%
1Y Performance:
+12.55%
1-Day Range:
Value
$2.54
$2.635
1-Week Range:
Value
$2.38
$2.635
52-Week Range:
Value
$1.60
$2.77

Cronos Group Inc Stock (CRON) Company Profile

Name
Name
Cronos Group Inc
Name
Phone
(416) 504-0004
Name
Address
4491 CONCESSION RD 12, STAYNER, ON
Name
Employee
459
Name
Twitter
@cronosgroup
Name
Next Earnings Date
2024-11-12
Name
Latest SEC Filings
Name
CRON's Discussions on Twitter

Compare CRON with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Drug Manufacturers - Specialty & Generic icon
CRON
Cronos Group Inc
2.60 968.84M 87.89M -73.96M -46.26M -0.1843
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
156.62 67.51B 9.39B 2.62B 2.22B 5.81
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
15.52 47.88B 29.96B 957.25M 4.77B 0.304
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
9.82 43.42B 14.26B 1.98B 2.47B 0.4347
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
18.46 20.72B 16.70B -157.13M 1.19B -0.155
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
312.23 14.21B 2.99B 1.21B 1.13B 25.06

Cronos Group Inc Stock (CRON) Upgrades & Downgrades

Date Action Analyst Rating Change
Nov-02-22 Initiated Bernstein Mkt Perform
Jul-28-22 Upgrade Canaccord Genuity Hold → Buy
May-11-22 Upgrade CIBC Neutral → Sector Outperform
Mar-22-22 Upgrade Barclays Underweight → Equal Weight
Jan-27-22 Upgrade Jefferies Underperform → Hold
Nov-18-21 Resumed BofA Securities Underperform
Apr-28-21 Resumed BofA Securities Underperform
Feb-22-21 Downgrade CIBC Sector Outperform → Neutral
Jun-24-20 Upgrade Raymond James Mkt Perform → Outperform
Apr-27-20 Downgrade Raymond James Outperform → Mkt Perform
Apr-14-20 Downgrade Piper Sandler Overweight → Neutral
Apr-02-20 Downgrade BofA/Merrill Buy → Neutral
Mar-31-20 Downgrade Canaccord Genuity Hold → Sell
Mar-04-20 Upgrade MKM Partners Neutral → Buy
Mar-03-20 Downgrade Stifel Buy → Hold
Oct-18-19 Upgrade Stifel Hold → Buy
Sep-20-19 Initiated MKM Partners Neutral
Sep-05-19 Upgrade BMO Capital Markets Underperform → Market Perform
Aug-13-19 Initiated Piper Jaffray Overweight
Aug-09-19 Upgrade Canaccord Genuity Sell → Hold
Jun-28-19 Initiated Consumer Edge Research Equal Weight
Jun-06-19 Initiated Stifel Hold
Jun-05-19 Upgrade BofA/Merrill Underperform → Buy
Apr-17-19 Initiated BofA/Merrill Underperform
Mar-27-19 Downgrade Canaccord Genuity Hold → Sell
Feb-25-19 Initiated Jefferies Underperform
Jan-18-19 Initiated CIBC Sector Outperform
View All

Cronos Group Inc Stock (CRON) Latest News

pulisher
Aug 20, 2025

Cronos Group Inc. (CRON) Invests $30M in High Tide to Fuel Canadian Cannabis Retail Expansion - MSN

Aug 20, 2025
pulisher
Aug 19, 2025

Cronos grows international footprint in Switzerland - MSN

Aug 19, 2025
pulisher
Aug 19, 2025

Cronos Group (CRON) Posts Double-Digit Cannabis Growth and Expands International Footprint - MSN

Aug 19, 2025
pulisher
Aug 18, 2025

Cronos Group (CRON.O): Unpacking a Sharp 5.7% Intraday Move Amid Quiet Fundamentals - AInvest

Aug 18, 2025
pulisher
Aug 18, 2025

Watch for Bullish Crossover in Cronos Group Inc.July 2025 Gainers & Daily Stock Trend Watchlist - kangso.co.kr

Aug 18, 2025
pulisher
Aug 18, 2025

Is Cronos Group Inc. forming a double bottomJuly 2025 Earnings & Safe Entry Point Identification - newsyoung.net

Aug 18, 2025
pulisher
Aug 15, 2025

Why Cronos Group Inc. stock attracts strong analyst attentionJuly 2025 Selloffs & Comprehensive Market Scan Insights - 선데이타임즈

Aug 15, 2025
pulisher
Aug 15, 2025

Will CRONOS GROUP INC COM NPV (OTCMKTS:PRMCF) Vertical Integration Strategy Lead To New Highs? - Insider Financial

Aug 15, 2025
pulisher
Aug 15, 2025

Cronos Group Inc. (NASDAQ:CRON) Q2 2025 Earnings Call Transcript - MSN

Aug 15, 2025
pulisher
Aug 15, 2025

What are Cronos Group Inc.’s earnings expectationsPortfolio Update Summary & Daily Volume Surge Trade Alerts - thegnnews.com

Aug 15, 2025
pulisher
Aug 15, 2025

Cronos Group Inc.'s (TSE:CRON) 26% Share Price Surge Not Quite Adding Up - simplywall.st

Aug 15, 2025
pulisher
Aug 15, 2025

Cronos Group’s Earnings Call Highlights Growth and Expansion - MSN

Aug 15, 2025
pulisher
Aug 14, 2025

Cronos Group Inc.’s Beta Climbs After Market VolatilityJuly 2025 Gainers & Precise Swing Trade Alerts - classian.co.kr

Aug 14, 2025
pulisher
Aug 14, 2025

Can Cronos Group Inc. Regain Lost Ground This Quarter2025 Key Highlights & Safe Entry Momentum Tips - beatles.ru

Aug 14, 2025
pulisher
Aug 14, 2025

What Does Cronos Group’s Revenue Growth and Rising Losses Reveal About Its Strategic Direction (TSX:CRON)? - simplywall.st

Aug 14, 2025
pulisher
Aug 13, 2025

Cronos Group Reports 21% Revenue Growth, Strong Gross Margin Improvement and International Expansion. - AInvest

Aug 13, 2025
pulisher
Aug 12, 2025

Cronos Group (CRON.O) Suffers Unusual Intraday Slide – What’s Behind It? - AInvest

Aug 12, 2025
pulisher
Aug 12, 2025

Cronos Group stock hits 52-week high at 2.72 USD - Investing.com

Aug 12, 2025
pulisher
Aug 12, 2025

Cronos Group Reports Strong Q2 2025 Performance - TipRanks

Aug 12, 2025
pulisher
Aug 11, 2025

Cronos stock rises on second quarter revenue growth - MSN

Aug 11, 2025
pulisher
Aug 11, 2025

Cronos Group and the Cannabis Rescheduling Catalyst: Strategic Positioning in a Regulatory-Transforming Market - AInvest

Aug 11, 2025
pulisher
Aug 11, 2025

Cronos Group Surges 15% Amid Trump Administration's Rescheduling Consideration - AInvest

Aug 11, 2025
pulisher
Aug 11, 2025

Cronos Rallies Amidst Greater Cannabis Sector Rally Over Possible Rescheduling (CRON) - Seeking Alpha

Aug 11, 2025
pulisher
Aug 11, 2025

CRON Soars 15% on Trump Marijuana Reclassification Hints and Q2 Earnings Surge – What’s Next? - AInvest

Aug 11, 2025
pulisher
Aug 11, 2025

Is Cronos Group’s Stock Set to Surge? - StocksToTrade

Aug 11, 2025
pulisher
Aug 11, 2025

Cronos Group is an undervalued stock, Roth says - Cantech Letter

Aug 11, 2025
pulisher
Aug 11, 2025

Cronos Group (CRON.O) Sharp Intraday Move: What’s Behind the Surge? - AInvest

Aug 11, 2025
pulisher
Aug 11, 2025

Exploring Three Undiscovered Gems in Canada with Strong Potential - Yahoo Finance

Aug 11, 2025
pulisher
Aug 11, 2025

Cronos Group Soars 20.87% on Trump's Marijuana Reclassification Hopes - AInvest

Aug 11, 2025
pulisher
Aug 09, 2025

Is Cronos Group Inc. gaining market shareBest Stocks for Explosive Gains - mustnews.co.kr

Aug 09, 2025
pulisher
Aug 08, 2025

Cronos Group 2025 Q2 Earnings Deepening Losses Despite Revenue Growth - AInvest

Aug 08, 2025
pulisher
Aug 08, 2025

Cronos Group shares fall 1.76% intraday after Q2 2025 earnings call. - AInvest

Aug 08, 2025
pulisher
Aug 08, 2025

Cronos Group Appoints New Principal Accounting Officer - The Globe and Mail

Aug 08, 2025
pulisher
Aug 08, 2025

Cronos: Q2 Earnings Snapshot - Connecticut Post

Aug 08, 2025
pulisher
Aug 07, 2025

Cronos Group signals expanded GrowCo capacity to drive growth amid 21% revenue increase - MSN

Aug 07, 2025
pulisher
Aug 07, 2025

Cronos Group's Q2 2025: Unpacking Contradictions in Gross Margins, GrowCo Expansion, and Market Performance - AInvest

Aug 07, 2025
pulisher
Aug 07, 2025

Cronos Group sees strong growth in international sales, but increased losses in Q2 2025 - StratCann

Aug 07, 2025
pulisher
Aug 07, 2025

Cronos Group (CRON.O) Sees Sharp Intraday Move—What’s Behind It? - AInvest

Aug 07, 2025
pulisher
Aug 07, 2025

Cronos Group Inc reports results for the quarter ended June 30Earnings Summary - TradingView

Aug 07, 2025
pulisher
Aug 07, 2025

Cronos stock rises on second quarter revenue growth (CRON) - Seeking Alpha

Aug 07, 2025
pulisher
Aug 07, 2025

Earnings call transcript: Cronos Group Q2 2025 reveals revenue growth amid EPS miss By Investing.com - Investing.com South Africa

Aug 07, 2025
pulisher
Aug 07, 2025

Earnings call transcript: Cronos Group Q2 2025 reveals revenue growth amid EPS miss - Investing.com Canada

Aug 07, 2025
pulisher
Aug 07, 2025

Earnings Snapshot: Cronos misses Q2 top-line and bottom-line estimates - MSN

Aug 07, 2025
pulisher
Aug 07, 2025

Cronos Group Reports 2025 Second Quarter Results - The Manila Times

Aug 07, 2025

Cronos Group Inc Stock (CRON) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading

Cronos Group Inc Stock (CRON) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
Weigensberg Arye
See Remarks
May 12 '25
Option Exercise
0.00
9,014
0
129,469
Weigensberg Arye
See Remarks
May 10 '25
Option Exercise
0.00
3,118
0
120,455
Wagner Adam
SVP, Head of Cronos Israel
May 12 '25
Option Exercise
0.00
6,276
0
57,435
Wagner Adam
SVP, Head of Cronos Israel
May 10 '25
Option Exercise
0.00
20,468
0
51,159
GORENSTEIN MICHAEL RYAN
See remarks below
Mar 21 '25
Option Exercise
0.00
3,000,000
0
13,689,272
Weigensberg Arye
See Remarks
Mar 15 '25
Option Exercise
0.00
24,236
0
117,337
Shlimak Anna
See Remarks
Mar 15 '25
Option Exercise
0.00
75,226
0
265,198
JACOBSON JEFFREY DAVID
Chief Growth Officer
Mar 15 '25
Option Exercise
0.00
90,957
0
387,271
Holm James
Chief Financial Officer
Mar 15 '25
Option Exercise
0.00
96,724
0
230,324
GORENSTEIN MICHAEL RYAN
See remarks below
Mar 15 '25
Option Exercise
0.00
355,900
0
10,789,384
$29.75
price up icon 2.37%
$17.91
price up icon 2.40%
drug_manufacturers_specialty_generic RDY
$14.51
price up icon 0.62%
$10.65
price down icon 0.37%
$135.43
price up icon 0.11%
$312.23
price up icon 0.51%
Cap:     |  Volume (24h):